- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/165 - Amides, p. ex. acides hydroxamiques ayant des cycles aromatiques, p. ex. colchicine, aténolol, progabide
Détention brevets de la classe A61K 31/165
Brevets de cette classe: 3597
Historique des publications depuis 10 ans
239
|
277
|
273
|
289
|
318
|
303
|
280
|
230
|
225
|
87
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
The Regents of the University of California | 19780 |
46 |
Novartis AG | 10975 |
40 |
Newron Pharmaceuticals S.p.A. | 61 |
40 |
Les Laboratoires Servier | 538 |
36 |
LTS Lohmann Therapie-Systeme AG | 691 |
23 |
Murray and Poole Enterprises Limited | 25 |
21 |
Allergan, Inc. | 2363 |
20 |
The General Hospital Corporation | 4695 |
19 |
Axsome Malta Ltd. | 76 |
19 |
President and Fellows of Harvard College | 5932 |
17 |
Indiana University Research and Technology Corporation | 795 |
17 |
Vanda Pharmaceuticals, Inc. | 352 |
16 |
Board of Regents, The University of Texas System | 5736 |
15 |
Dana-Farber Cancer Institute, Inc. | 2545 |
15 |
Bristol-myers Squibb Company | 4897 |
14 |
BIAL - Portela & CA, S.A. | 224 |
14 |
Children's Medical Center Corporation | 1839 |
14 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2832 |
14 |
The Trustees of the University of Pennsylvania | 4289 |
13 |
The Johns Hopkins University | 5626 |
12 |
Autres propriétaires | 3172 |